Comparison of second-generation screening and confirmatory assays with recombinant antigens and synthetic peptides against antibodies to hepatitis C virus

A study in penal patients

F. Fabrizi, I. Raffaele, I. Guarnori, G. Bacchini, P. Marai, G. Erba, F. Locatelli

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The aim of this study was to compare some common tests which are nowadays routinely used to screen and to confirm anti-HCV antibodies in renal patients. There was agreement between Ortho 2 and Abbott 2 in 94% of samples; structural and nonstructural beads of the Abbott supplementary assay were in agreement with 4-RIBA in 98 and in 85% of samples, respectively; 61% of Ortho 2 samples and 65% of Abbott 2 samples were confirmed by 4-RIBA; there was a correlation between semiquantitative analysis of screening tests (Ortho 2 and Abbott 2) and positive results by 4-RIBA; 36 and 33% of Ortho-2- and Abbott-2-positive samples were 4-RIBA indeterminate: in these instances more sophisticated techniques (polymerase chain reaction) (PCR) could be useful as a third-level assay. The comparison between Ortho 2, based on recombinant antigens, and Innotest, based on synthetic peptides, showed agreement only in 44% of samples, but this preliminary comparison cannot afford definitive conclusions. These findings suggest that second-generation assays may sometimes yield conflicting results in renal patients. These contradictions will be resolved by new HCV tests or PCR.

Original languageEnglish
Pages (from-to)444-448
Number of pages5
JournalNephron
Volume69
Issue number4
Publication statusPublished - 1995

Fingerprint

Hepatitis A virus
Synthetic Vaccines
Kidney
Polymerase Chain Reaction
Peptides
Hepatitis C Antibodies
Antibodies
Antigens

Keywords

  • 4-RIBA
  • Abbott 2
  • Anti-HCV antibodies
  • Hepatitis C virus infection
  • Ortho 2

ASJC Scopus subject areas

  • Nephrology

Cite this

Comparison of second-generation screening and confirmatory assays with recombinant antigens and synthetic peptides against antibodies to hepatitis C virus : A study in penal patients. / Fabrizi, F.; Raffaele, I.; Guarnori, I.; Bacchini, G.; Marai, P.; Erba, G.; Locatelli, F.

In: Nephron, Vol. 69, No. 4, 1995, p. 444-448.

Research output: Contribution to journalArticle

@article{db976ab031b04e6781f3bb2c94d66e6e,
title = "Comparison of second-generation screening and confirmatory assays with recombinant antigens and synthetic peptides against antibodies to hepatitis C virus: A study in penal patients",
abstract = "The aim of this study was to compare some common tests which are nowadays routinely used to screen and to confirm anti-HCV antibodies in renal patients. There was agreement between Ortho 2 and Abbott 2 in 94{\%} of samples; structural and nonstructural beads of the Abbott supplementary assay were in agreement with 4-RIBA in 98 and in 85{\%} of samples, respectively; 61{\%} of Ortho 2 samples and 65{\%} of Abbott 2 samples were confirmed by 4-RIBA; there was a correlation between semiquantitative analysis of screening tests (Ortho 2 and Abbott 2) and positive results by 4-RIBA; 36 and 33{\%} of Ortho-2- and Abbott-2-positive samples were 4-RIBA indeterminate: in these instances more sophisticated techniques (polymerase chain reaction) (PCR) could be useful as a third-level assay. The comparison between Ortho 2, based on recombinant antigens, and Innotest, based on synthetic peptides, showed agreement only in 44{\%} of samples, but this preliminary comparison cannot afford definitive conclusions. These findings suggest that second-generation assays may sometimes yield conflicting results in renal patients. These contradictions will be resolved by new HCV tests or PCR.",
keywords = "4-RIBA, Abbott 2, Anti-HCV antibodies, Hepatitis C virus infection, Ortho 2",
author = "F. Fabrizi and I. Raffaele and I. Guarnori and G. Bacchini and P. Marai and G. Erba and F. Locatelli",
year = "1995",
language = "English",
volume = "69",
pages = "444--448",
journal = "Experimental Nephrology",
issn = "0028-2766",
publisher = "S. Karger AG",
number = "4",

}

TY - JOUR

T1 - Comparison of second-generation screening and confirmatory assays with recombinant antigens and synthetic peptides against antibodies to hepatitis C virus

T2 - A study in penal patients

AU - Fabrizi, F.

AU - Raffaele, I.

AU - Guarnori, I.

AU - Bacchini, G.

AU - Marai, P.

AU - Erba, G.

AU - Locatelli, F.

PY - 1995

Y1 - 1995

N2 - The aim of this study was to compare some common tests which are nowadays routinely used to screen and to confirm anti-HCV antibodies in renal patients. There was agreement between Ortho 2 and Abbott 2 in 94% of samples; structural and nonstructural beads of the Abbott supplementary assay were in agreement with 4-RIBA in 98 and in 85% of samples, respectively; 61% of Ortho 2 samples and 65% of Abbott 2 samples were confirmed by 4-RIBA; there was a correlation between semiquantitative analysis of screening tests (Ortho 2 and Abbott 2) and positive results by 4-RIBA; 36 and 33% of Ortho-2- and Abbott-2-positive samples were 4-RIBA indeterminate: in these instances more sophisticated techniques (polymerase chain reaction) (PCR) could be useful as a third-level assay. The comparison between Ortho 2, based on recombinant antigens, and Innotest, based on synthetic peptides, showed agreement only in 44% of samples, but this preliminary comparison cannot afford definitive conclusions. These findings suggest that second-generation assays may sometimes yield conflicting results in renal patients. These contradictions will be resolved by new HCV tests or PCR.

AB - The aim of this study was to compare some common tests which are nowadays routinely used to screen and to confirm anti-HCV antibodies in renal patients. There was agreement between Ortho 2 and Abbott 2 in 94% of samples; structural and nonstructural beads of the Abbott supplementary assay were in agreement with 4-RIBA in 98 and in 85% of samples, respectively; 61% of Ortho 2 samples and 65% of Abbott 2 samples were confirmed by 4-RIBA; there was a correlation between semiquantitative analysis of screening tests (Ortho 2 and Abbott 2) and positive results by 4-RIBA; 36 and 33% of Ortho-2- and Abbott-2-positive samples were 4-RIBA indeterminate: in these instances more sophisticated techniques (polymerase chain reaction) (PCR) could be useful as a third-level assay. The comparison between Ortho 2, based on recombinant antigens, and Innotest, based on synthetic peptides, showed agreement only in 44% of samples, but this preliminary comparison cannot afford definitive conclusions. These findings suggest that second-generation assays may sometimes yield conflicting results in renal patients. These contradictions will be resolved by new HCV tests or PCR.

KW - 4-RIBA

KW - Abbott 2

KW - Anti-HCV antibodies

KW - Hepatitis C virus infection

KW - Ortho 2

UR - http://www.scopus.com/inward/record.url?scp=0028915286&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028915286&partnerID=8YFLogxK

M3 - Article

VL - 69

SP - 444

EP - 448

JO - Experimental Nephrology

JF - Experimental Nephrology

SN - 0028-2766

IS - 4

ER -